Australian guidelines for the clinical care of people with COVID-19 - Australian National COVID-19 Clinical Evidence Taskforce
s.l; National COVID-19 Clinical Evidence Taskforce; 2020. 215 p.
Monography
in English
| BIGG - GRADE guidelines
| ID: biblio-1116720
Responsible library:
BR1.1
ABSTRACT
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in the prevention of COVID-19 infection or transmission. Within each recommendation, the patient population of interest is specified.
Full text:
Available
Collection:
Tematic databases
Health context:
SDG3 - Target 3.3 End transmission of communicable diseases
/
SDG3 - Target 3.1 Reduce Maternal Mortality
Health problem:
Pneumonia
/
Maternal Care
Database:
BIGG - GRADE guidelines
Main subject:
Antiviral Agents
/
Plasma
/
Pneumonia, Viral
/
Dexamethasone
/
Clinical Diagnosis
/
Colchicine
/
Interferons
/
Coronavirus Infections
/
Patient Acuity
/
Darunavir
Type of study:
Diagnostic study
/
Practice guideline
Aspects:
Patient-preference
Language:
English
Year:
2020
Document type:
Monography
